NCT00261937已完成1 期
Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 2
- 主要终点
- Clinical respiratory effects
研究概览
简要总结
We hypothesize that inhaled Furosemide will be an effective treatment in infants with acute bronchiolitis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 1 Day 至 12 Months（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age: 0-12 months.
- •Infants who are otherwise healthy
- •Infants with chronic lung disease of prematurity (BPD) will be included, but will be analyzed separately.
- •Parents signed a written informed consent.
排除标准
- •• Other previous or co-morbidity, specifically: respiratory (other than BPD, like Asthma or Cystic Fibrosis), cardiac or renal disease or anomaly.
结局指标
主要结局
Clinical respiratory effects
次要结局
- 1. The duration of hospitalization
- 2. Time weaned off oxygen
- 3. Time to full enteral feeding
研究者
研究点 (2)
Loading locations...
相似试验
撤回
早期 1 期
Nebulized Furosemide in Premature Infants With Bronchopulmonary Dysplasia - A Cross Over Pilot Study of Its Efficacy and SafetyPremature InfantPremature BirthNCT03946891NYU Langone Health
已完成
2 期
Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient TachypnoeaTransient Tachypnoea of the NewbornNCT01407848University of Cologne20
已完成
2 期
Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)Bronchopulmonary DysplasiaNCT02527798University of North Carolina, Chapel Hill82
终止
2 期
Furosemide as Supportive Therapy for COVID-19 Respiratory FailureCovid19Respiratory FailureNCT04588792Dr. John Muscedere40
已完成
不适用
Inhaled Furosemide for Transient Tachypnea of NewbornRespiratory MorbidityNCT04397991Makassed General Hospital64